The ability to evaluate the efficacy of a given treatment for cancer is critical in achieving the best prognosis and care for patients. However, most standard methods of treatment response evaluation rely on visualizing a change in tumor size, which often occurs months after treatment begins.

Until recently, certain types of cancer patients had very few or no options after they had been turned down as ...